Broad prebiotic potential of non-starch polysaccharides from oats (Avena sativa L.): an in vitro study

• Autorzy: Sargautiene V. , Nakurte I. , Nikolajeva V.
• Języki publikacji: EN

Abstrakty

EN

Prebiotics inducing the growth or activity of beneficial intestinal bacteria – probiotics producing short-chain fatty acids (SCFA) have lately received wide recognition for their beneficial influence on host intestinal microbiota and metabolic health. Some non-starch polysaccharides (NSP) are defined as prebiotics and oats being one of richest sources of NSP in grains are considered as potentially having prebiotic effect. However, information on fermentation of specific NSP of oats is limited. Moreover, bacterial cross-feeding interactions in which fermentation of prebiotics is involved is poorly characterized. Here, we report the exploration of new candidates for the syntrophic bacterial interactions and fermentability of oat non-starch polysaccharides (NSP). The results obtained by differentiating composition, viscosity and concentration of oats NSP in fermentation medium showed that Bacillus licheniformis pre-digests oat NSP, degrades high viscosity of oat β-glucan and makes hemicellulose easier to access for other bacteria. Because of fermentation, B. licheniformis produces lactic and succinic acids, which further can be used by other bacteria for cross-feeding and SCFA production.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2018
• Tom: 67
• Numer: 3
• Opis fizyczny: p.307-313,fig.,ref.

Twórcy

autor

Sargautiene V.

• Department of Internal Medicine, University of Latvia, Riga, Latvia

autor

Nakurte I.

• Department of Physical Chemistry, University of Latvia, Riga, Latvia

autor

Nikolajeva V.

• Department of Microbiology and Biotechnology, University of Latvia, Riga, Latvia

Bibliografia

• Anttila H, Sontag-Strohm T, Salovaara H. 2008. Viscosity of beta-glucan in oat products. AFSci. 13(1–2):80–87.
• Arbsuwan N, Payoungkiattikun W, Sirithorn P, Daduang S, Jangpromma N, Dhiravisit A, Tae Hahm Y, Kurt Neubert L, Klaynongsruang S. 2017. Purification and characterization of macrolactins and amicoumacins from Bacillus licheniformis BFP011: a new source of food antimicrobial substances. CyTA – Journal of Food. 16(1):50–60.
• Ferrer I, Thurman EM. 2003. Liquid chromatography time – of– flight/ mass spectrometry (LC/TOF/MS) for the analysis of emerging contaminants. Trends Anal Chem. 22(10):750–756.
• Gopal N, Hill C, Ross PR, Beresford TP, Fenelon MA, Cotter PD. 2015. The prevalence and control of Bacillus and related spore-forming bacteria in the dairy industry. Front Microbiol. 21(6):1418.
• Hamady ZZR. 2013. Novel xylan-controlled delivery of therapeutic proteins to inflamed colon by the human anaerobic commensal bacterium. Ann R Coll Surg Engl. 95(4):235–240.
• Han J, Lin K, Sequeira C, Borchers CH. 2015. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 7(854):86–94.
• Heo J, Kim SK, Park KS, Jung HK, Kwon JG, Jang BI. 2014. A double-blind, randomized, active drug comparative, parallel-group, multi-center clinical study to evaluate the safety and efficacy of probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in patients with diarrhea. Intest Res. 12(3):236–244.
• Holguin-Acun AL, Ramos-Chavira N, Carvajal-Millan E, Santana-Rodriguez V, Rasco´n-Chu A, Niño-Medina G. 2011. Non-starch polysaccharides in maize and oat. In: Preedy VR, Watson RR, Patel VB, editors. Flour and breads and their fortification in health and disease prevention. 1st ed. San Diego, California (USA): Academic Press. p. 542.
• Hong PY, Wu JH, Liu WT. 2008. Relative abundance of Bacteroides spp. in stools and wastewaters as determined by hierarchical oligonucleotide primer extension. Appl Environ Microbiol. 74(9):2882–2893.
• Ibanez AB, Bauer S. 2014. Analytical method for the determination of organic acids in dilute acid pretreated biomass hydrolysate by liquid chromatography-time-of-flight mass spectrometry. Biotechnol Biofuels. 7(1):145.
• Jia L, Li D, Feng N, Shamoon M, Sun Z, Ding L, Zhang H, Chen W, Sun J, Chen YQ. 2017. Anti-diabetic effects of Clostridium butyricum CGMCC0313.1 through promoting the growth of gut butyrateproducing bacteria in type 2 diabetic mice. Sci Rep. 7(1):7046.
• Jordan DB, Stoller JR, Lee CC, Chan VJ, Wagschal K. 2017. Biochemical characterization of a GH43 β-xylosidase from Bacteroides ovatus. Appl Biochem Biotechnol. 182(1): 250–260.
• Kaletunc G, Breslauer K. 2003. Characterization of cereals and flours. 1st ed. Boca Raton (USA): CRC Press.
• Kanai T, Mikami Y, Hayashi A. 2015. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease. J Gastroenterol. 50(9):928–939.
• Martín R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermudez-Humaran LG. 2013. Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microb Cell Fact. 12:71.
• McCleary BV, Glennie-Holmes M. 1985. Enzymic quantification of (1→3) (1→4)-β-D-glucan in barley and malt. JIB. 91(5): 285–295.
• McFarlin BK, Henning AL, Bowman EM, Gary MA, Carbajal KM. 2017. Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers. World J Gastrointest Pathophysiol. 8(3):117–126.
• Miller SS, Fulcher RG. 2011. Microstructure and Chemistry of the Oat Kernel. In: Webster FH, Wood PJ, editors. Oats: Chemistry and Technology. 2nd ed. St.Paul, Minnesota (U.S.A.): AACC International. p. 77–94.
• Montoya D, Arévalo C, Gonzales S, Aristizabal F, Schwarz WH. 2001. New solvent-producing Clostridium sp. strains, hydrolyzing a wide range of polysaccharides, are closely related to Clostridium butyricum. J Ind Microbiol Biotech. 27(5):329–335.
• Morrison DJ, Preston T. 2016. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 7(3):189–200.
• Nakajima N, Ishihara K, Matsuura Y. 2002. Dietary-fiber-degrading enzymes from a human intestinal Clostridium and their application to oligosaccharide production from nonstarchy polysaccharides using immobilized cells. Appl Microbiol Biotechnol. 59: 82–189.
• Pepe O, Blaiotta G, Moshetti G, Greco T, Villani F. 2003. Rope-producing strains of Bacillus spp. from wheat bread and strategy for their control by lactic acid bacteria. Appl Environ Microbiol. 69(4):2321–2329.
• Planas A. 2000. Bacterial 1,3-1,4-beta-glucanases: structure, function and protein engineering. Biochim Biophys Acta. 1543(2):361–382.
• Rajilić-Stojanović M, de Vos W. 2014. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 38(5):996–1047.
• Rakoff-Nahoum S, Foster K, Comstock L. 2016. The evolution of cooperation within the gut microbiota. Nature. 533(7602):255–259.
• Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, Flint HJ, Louis P. 2014. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8(6):1323–1335.
• Roberfroid M. 2007. Prebiotics: the concept revisited. J Nutr. 137(3 Suppl 2):830S–837S.
• Sahasrabudhe NM, Tian L, van den Berg M, Bruggeman G, Bruininx E, Schols HA, Faas MM, de Vos P. 2016. Endo-glucanase digestion of oat beta-glucan enhances Dectin-1 activation in human dendritic cells. J Funct Foods. 21:104–112.
• Sun J, Wang F, Ling Z, Yu X, Chen W, Li H, Jin J, Pang M, Zhang H, Yu J, Liu J. 2016. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Res. 1642:180–188.
• Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S. 2012. Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate. Appl Environ Microbiol. 78(2):528–535.

Identyfikatory

DOI

10.21307/pjm-2018-036